Healthcare & Medical Devices Global On demand · 24-48h

Global AR and VR Medical Device Market Strategic Research Report

Global AR and VR Medical Device Market Strategic Research Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global AR and VR Medical Device Market
$3.67B2025
12.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Virtual Reality (VR) Medical Device, Augmented Reality (AR) Medical Device

By Application: Hospital, Rehabilitation Center, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Augmedics, Inc., VB Spine, LLC, Tyromotion GmbH, Xironetic, Inc., Proprio, Inc., Vuzix Corporation, BHS Technologies, Novarad Corporation, RealView Imaging Ltd., Surgical Theater, Inc., Shanghai Linyan Medical Technology Co., Ltd., Shanghai Futuo Zhida Medical Technology Co., Ltd., Henan Xiangyu Medical Equipment Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 108 pages
Market size 2025
$3.67B
Billion USD
Forecast CAGR
12.4%
2025-2032
Forecast 2032
$8.3B
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global AR and VR Medical Device market size is predicted to grow from US$ 3,668 million in 2025 to US$ 8,292 million in 2032; it is expected to grow at a CAGR of 12.4% from 2026 to 2032.

AR and VR medical device refers to device that integrate immersive technologies such as VR (virtual reality) and AR (augmented reality) into tangible, independently operable hardware products for clinical use as medical devices. These devices typically include physical carriers such as head-mounted displays, smart glasses, and handheld probes, and incorporate medical-standard software algorithms to form a complete medical device. Augmented reality and virtual reality medical devices, through hardware such as AR/VR headsets, convert patient image data into transparent holographic images and precisely overlay them onto the surgical field, solving the problems of hand-eye separation and reliance on spatial imagination required in traditional surgery, achieving "seeing through the skin for surgery." Simultaneously, they create an immersive virtual treatment environment for patients, addressing the issues of monotonous traditional rehabilitation training and the difficulty in constructing psychological treatment scenarios, and providing a repeatable, risk-free medical teaching platform, improving diagnostic accuracy, patient compliance, and the efficiency of medical education. The upstream mainly includes core hardware and underlying technology suppliers, such as manufacturers providing chips, sensors, cameras, and display modules, as well as software algorithm providers responsible for medical image data processing and 3D reconstruction. The downstream consists of end users and application scenarios for medical devices, namely medical institutions at all levels (hospitals, surgical centers, rehabilitation centers) using the equipment for clinical diagnosis and treatment, and medical schools using it for teaching and training. These devices typically reach end users through professional medical device distributors or direct supply from manufacturers. In 2025, the production volume of augmented reality and virtual reality medical devices is estimated at approximately 1.5 million units, with an average price of approximately US$2,500 per unit, a gross profit margin of approximately 45%, and a single-line production capacity of 20,000 units per year.

Global key AR and VR Medical Device players cover Augmedics, Inc., VB Spine, LLC, Tyromotion GmbH, Xironetic, Inc., Proprio, Inc., etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global AR and VR Medical Device market?

What factors are driving AR and VR Medical Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do AR and VR Medical Device market opportunities vary by end market size?

How does AR and VR Medical Device break out by Type, by Application?

This report presents a comprehensive overview of the global AR and VR Medical Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Virtual Reality (VR) Medical Device
  • Augmented Reality (AR) Medical Device

Segment by Tracking Technology

  • Marker-Based Tracking Device
  • Marker-Less Tracking Device

Segment by Application

  • Hospital
  • Rehabilitation Center
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global AR and VR Medical Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Rehabilitation Center, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global AR and VR Medical Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 12.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.67B
2025
Forecast
$8.3B
2032
CAGR
12.4%
2025–2032
リージョン
5
global
Key companies
Augmedics, Inc.VB Spine, LLCTyromotion GmbHXironetic, Inc.Proprio, Inc.Vuzix CorporationBHS TechnologiesNovarad Corporation
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Virtual Reality (VR) Medical DeviceAugmented Reality (AR) Medical Device
By Application
HospitalRehabilitation CenterOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Virtual Reality (VR) Medical Device
  • 3.1.3 Augmented Reality (AR) Medical Device
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Rehabilitation Center
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Augmedics, Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 VB Spine, LLC
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Tyromotion GmbH
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Xironetic, Inc.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Proprio, Inc.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Vuzix Corporation
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 BHS Technologies
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Novarad Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 RealView Imaging Ltd.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Surgical Theater, Inc.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shanghai Linyan Medical Technology Co., Ltd.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Shanghai Futuo Zhida Medical Technology Co., Ltd.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Henan Xiangyu Medical Equipment Co., Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global AR and VR Medical Device market?
The global AR and VR Medical Device market is estimated at US$ 3.67 billion in 2025 (base year) and is projected to reach US$ 8.29 billion by 2032.
How fast is the AR and VR Medical Device market expected to grow?
The market is expected to grow at a CAGR of 12.4% from 2026 to 2032, expanding from US$ 3.67 billion in 2025 to US$ 8.29 billion in 2032, roughly 2.3 times its base-year value.
What does the AR and VR Medical Device market cover?
AR and VR medical device refers to device that integrate immersive technologies such as VR (virtual reality) and AR (augmented reality) into tangible, independently operable hardware products for clinical use as medical devices. These devices typically include physical carriers such as head-mounted displays, smart glasses, and handheld probes, and incorporate medical-standard software algorithms to form a complete medical device.
How is the AR and VR Medical Device market segmented by type?
By type, the market is segmented into Virtual Reality (VR) Medical Device and Augmented Reality (AR) Medical Device.
What are the key applications of AR and VR Medical Device?
Key applications covered include Hospital, Rehabilitation Center and Other.
Which companies are profiled in the AR and VR Medical Device market report?
Key players profiled include Augmedics, VB Spine, Tyromotion GmbH, Xironetic, Proprio, Vuzix Corporation, BHS Technologies and Novarad Corporation, among 13 companies covered in total.
What geographies does the AR and VR Medical Device market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for AR and VR Medical Device?
What factors are driving AR and VR Medical Device market growth, globally and by region?
Who should buy the AR and VR Medical Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Rehabilitation Center and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the AR and VR Medical Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.